These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 24269245)

  • 1. Evaluation of hypoglycemic activity of total lignans from Fructus Arctii in the spontaneously diabetic Goto-Kakizaki rats.
    Xu Z; Ju J; Wang K; Gu C; Feng Y
    J Ethnopharmacol; 2014; 151(1):548-55. PubMed ID: 24269245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
    Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
    J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arctigenic acid, the key substance responsible for the hypoglycemic activity of Fructus Arctii.
    Xu Z; Gu C; Wang K; Ju J; Wang H; Ruan K; Feng Y
    Phytomedicine; 2015 Jan; 22(1):128-37. PubMed ID: 25636881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of hypoglycemia and weight loss of total lignans from Fructus Arctii in KKAy mice and its mechanisms of the activity.
    Gao Y; Gu C; Wang K; Wang H; Ruan K; Xu Z; Feng Y
    Phytother Res; 2018 Apr; 32(4):631-642. PubMed ID: 29235180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antidiabetic activity of total lignan from Fructus Arctii against alloxan-induced diabetes in mice and rats.
    Xu Z; Wang X; Zhou M; Ma L; Deng Y; Zhang H; Zhao A; Zhang Y; Jia W
    Phytother Res; 2008 Jan; 22(1):97-101. PubMed ID: 17724763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
    Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased secretion and expression of amylin in spontaneously diabetic Goto-Kakizaki rats treated with rhGLP-1 (7-36).
    Weng HB; Gu Q; Liu M; Cheng NN; Li D; Gao X
    Acta Pharmacol Sin; 2008 May; 29(5):573-9. PubMed ID: 18430365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.
    Pacheco D; de Luis DA; Romero A; González Sagrado M; Conde R; Izaola O; Aller R; Delgado A
    Am J Surg; 2007 Aug; 194(2):221-4. PubMed ID: 17618808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatographic fingerprint combined with quantitative analysis of multi-components by single-marker for quality control of total lignans from Fructus arctii by high-performance liquid chromatography.
    Zhang JY; Mei JW; Wang HY; Xu ZH
    Phytochem Anal; 2022 Dec; 33(8):1214-1224. PubMed ID: 36131366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats.
    Higuchi N; Hira T; Yamada N; Hara H
    Endocrinology; 2013 Sep; 154(9):3089-98. PubMed ID: 23798598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sleeve gastrectomy on body weight, food intake, glucose tolerance, and metabolic hormone level in two different rat models: Goto-Kakizaki and diet-induced obese rat.
    Trung VN; Yamamoto H; Yamaguchi T; Murata S; Akabori H; Ugi S; Maegawa H; Tani T
    J Surg Res; 2013 Nov; 185(1):159-65. PubMed ID: 23746960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
    Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
    J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrient-driven incretin secretion into intestinal lymph is different between diabetic Goto-Kakizaki rats and Wistar rats.
    Kindel TL; Yang Q; Yoder SM; Tso P
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G168-74. PubMed ID: 19056762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats.
    Jeppesen PB; Gregersen S; Alstrup KK; Hermansen K
    Phytomedicine; 2002 Jan; 9(1):9-14. PubMed ID: 11924770
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zambrana S; Lundqvist LCE; Mamani O; Catrina SB; Gonzales E; Östenson CG
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037028
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of New Modified Biliopancreatic Diversion on Blood Glucose and Lipids in GK rats.
    Weng S; Zhang B; Xu C; Feng S; He H
    Obes Surg; 2017 Mar; 27(3):657-664. PubMed ID: 27525641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.
    Patriti A; Aisa MC; Annetti C; Sidoni A; Galli F; Ferri I; Gullà N; Donini A
    Surgery; 2007 Jul; 142(1):74-85. PubMed ID: 17630003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice.
    Xiong WT; Gu L; Wang C; Sun HX; Liu X
    J Ethnopharmacol; 2013 Dec; 150(3):935-45. PubMed ID: 24095831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic toxicity in Sprague-Dawley rats of orally-administered total lignans from Arctii Fructus, a potential therapeutic drug for diabetes.
    Mei J; Li X; Xu Z; Zhao H; Zhang J; Xu Q; Xu Z
    Regul Toxicol Pharmacol; 2024 Jan; 146():105542. PubMed ID: 38070762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.